OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms
Dwight H. Owen, Brooke Benner, Lai Wei, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 4, pp. 731-741
Open Access | Times Cited: 24
Dwight H. Owen, Brooke Benner, Lai Wei, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 4, pp. 731-741
Open Access | Times Cited: 24
Showing 24 citing articles:
The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high‐grade transformation
Samuel Backman, Johan Botling, Helena Nord, et al.
The Journal of Pathology (2024) Vol. 264, Iss. 4, pp. 357-370
Open Access | Times Cited: 7
Samuel Backman, Johan Botling, Helena Nord, et al.
The Journal of Pathology (2024) Vol. 264, Iss. 4, pp. 357-370
Open Access | Times Cited: 7
Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns
Yu Jiang, Yi-han Dong, Shiwei Zhao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Yu Jiang, Yi-han Dong, Shiwei Zhao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma
Akira Ooki, Hiroki Osumi, Koshiro Fukuda, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 1021-1054
Open Access | Times Cited: 10
Akira Ooki, Hiroki Osumi, Koshiro Fukuda, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 1021-1054
Open Access | Times Cited: 10
Basic science and translational implications of current knowledge on neuroendocrine tumors
Lynnette Fernandez-Cuesta, Nicolas Alcala, Emilie Mathian, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 5
Open Access
Lynnette Fernandez-Cuesta, Nicolas Alcala, Emilie Mathian, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 5
Open Access
Liver Transplantation for Non-Hepatocellular Carcinoma: Role of Immune Checkpoint Inhibitors
Pegah Bahrami, Mohammad Al Zein, Ali H. Eid, et al.
Journal of Clinical and Experimental Hepatology (2025), pp. 102558-102558
Closed Access
Pegah Bahrami, Mohammad Al Zein, Ali H. Eid, et al.
Journal of Clinical and Experimental Hepatology (2025), pp. 102558-102558
Closed Access
Immuntherapie bei neuroendokrinen Neoplasien des Gastrointestinaltrakts
Sebastian Krug, Leonidas Apostolidis
Deleted Journal (2025)
Closed Access
Sebastian Krug, Leonidas Apostolidis
Deleted Journal (2025)
Closed Access
Selecting optimal therapy for advanced nonfunctional pancreatic neuroendocrine tumors: latest research and therapeutic advances
Ruba Alchaikh Hassan, Arti C. Patel, Constantin A Dasanu
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Ruba Alchaikh Hassan, Arti C. Patel, Constantin A Dasanu
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Current and emerging strategies for the management of advanced/metastatic lung neuroendocrine tumors
Megan J. Rutherford, Margaret Wheless, Katharine Thomas, et al.
Current Problems in Cancer (2024) Vol. 49, pp. 101061-101061
Closed Access | Times Cited: 3
Megan J. Rutherford, Margaret Wheless, Katharine Thomas, et al.
Current Problems in Cancer (2024) Vol. 49, pp. 101061-101061
Closed Access | Times Cited: 3
Lung NETs and GEPNETs: One Cancer with Different Origins or Two Distinct Cancers?
George Evangelou, Ioannis Vamvakaris, Anastasia Papafili, et al.
(2024)
Open Access | Times Cited: 3
George Evangelou, Ioannis Vamvakaris, Anastasia Papafili, et al.
(2024)
Open Access | Times Cited: 3
Immunotherapy in Neuroendocrine Neoplasms: A Diamond to Cut
Esmeralda García‐Torralba, Esther Garcia-Lorenzo, Bernard Doger, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2530-2530
Open Access | Times Cited: 3
Esmeralda García‐Torralba, Esther Garcia-Lorenzo, Bernard Doger, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2530-2530
Open Access | Times Cited: 3
ETV6-NTRK2 Fusion in a Patient With Metastatic Pulmonary Atypical Carcinoid Successfully Treated With Entrectinib: A Case Report and Review of the Literature
Wusheng Zhang, Sen Tian, X. Li, et al.
Clinical Lung Cancer (2024) Vol. 25, Iss. 3, pp. 215-224.e3
Closed Access | Times Cited: 2
Wusheng Zhang, Sen Tian, X. Li, et al.
Clinical Lung Cancer (2024) Vol. 25, Iss. 3, pp. 215-224.e3
Closed Access | Times Cited: 2
Challenges and future perspectives for the use of temozolomide in the treatment of SCLC
Elisa Andrini, Gianluca Ricco, Arianna Zappi, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102798-102798
Closed Access | Times Cited: 2
Elisa Andrini, Gianluca Ricco, Arianna Zappi, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102798-102798
Closed Access | Times Cited: 2
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms
Siren Morken, Seppo W. Langer, Anna Sundlöv, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 12, pp. 1930-1939
Open Access | Times Cited: 6
Siren Morken, Seppo W. Langer, Anna Sundlöv, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 12, pp. 1930-1939
Open Access | Times Cited: 6
Narrative Review of Immunotherapy in Gastroentero-Pancreatic Neuroendocrine Neoplasms
Jasmeet Kaur, Namrata Vijayvergia
Current Oncology (2023) Vol. 30, Iss. 9, pp. 8653-8664
Open Access | Times Cited: 5
Jasmeet Kaur, Namrata Vijayvergia
Current Oncology (2023) Vol. 30, Iss. 9, pp. 8653-8664
Open Access | Times Cited: 5
Effectiveness of Atezolizumab in Metastatic Large Cell Neuroendocrine Carcinoma of the Lung and the Predictive Value of miR-375. The LANCE Trial, a Pilot Study
George Evangelou, Ioannis Trontzas, Ioannis Gkiozos, et al.
(2024)
Open Access | Times Cited: 1
George Evangelou, Ioannis Trontzas, Ioannis Gkiozos, et al.
(2024)
Open Access | Times Cited: 1
Lung NETs and GEPNETs: One Cancer with Different Origins or Two Distinct Cancers?
George Evangelou, Ioannis Vamvakaris, Anastasia Papafili, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1177-1177
Open Access | Times Cited: 1
George Evangelou, Ioannis Vamvakaris, Anastasia Papafili, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1177-1177
Open Access | Times Cited: 1
Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies
Leonidas Nikolaos Diamantopoulos, Markos Kalligeros, Þorvarður R. Hálfdánarson, et al.
Biology (2023) Vol. 12, Iss. 8, pp. 1069-1069
Open Access | Times Cited: 2
Leonidas Nikolaos Diamantopoulos, Markos Kalligeros, Þorvarður R. Hálfdánarson, et al.
Biology (2023) Vol. 12, Iss. 8, pp. 1069-1069
Open Access | Times Cited: 2
The Evolutionary History of Metastatic Pancreatic Neuroendocrine Tumours Reveals a Therapy Driven Route to High-Grade Transformation
Samuel Backman, Johan Botling, Helena Nord, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Samuel Backman, Johan Botling, Helena Nord, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Neuroendocrine tumors of the lung: state of the art
Barbara Kiesewetter, Philipp Melhorn, Markus Raderer
Deleted Journal (2024) Vol. 17, Iss. 1, pp. 2-8
Open Access
Barbara Kiesewetter, Philipp Melhorn, Markus Raderer
Deleted Journal (2024) Vol. 17, Iss. 1, pp. 2-8
Open Access
The Effectiveness of Atezolizumab in Metastatic Large Cell Neuroendocrine Carcinoma of the Lungs: Insights from the LANCE Pilot Study
George Evangelou, Ioannis Trontzas, Ioannis Gkiozos, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1161-1161
Open Access
George Evangelou, Ioannis Trontzas, Ioannis Gkiozos, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1161-1161
Open Access
Management of typical and atypical metastatic lung carcinoids: present and future perspectives
Ana Rodrigues, Rui Henrique, Cármen Jerónimo, et al.
Clinical & Translational Oncology (2024) Vol. 27, Iss. 3, pp. 816-823
Open Access
Ana Rodrigues, Rui Henrique, Cármen Jerónimo, et al.
Clinical & Translational Oncology (2024) Vol. 27, Iss. 3, pp. 816-823
Open Access
Unraveling the mysteries of MGMT: Implications for neuroendocrine tumors
JianyunJiang, Junfeng Xu, Shunrong Ji, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189184-189184
Closed Access
JianyunJiang, Junfeng Xu, Shunrong Ji, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189184-189184
Closed Access
Selecting systemic treatment for metastatic neuroendocrine tumors of the lung—current evidence and clinical implications
Philipp Melhorn, Markus Raderer, Barbara Kiesewetter
Cancer Treatment Reviews (2024) Vol. 133, pp. 102878-102878
Open Access
Philipp Melhorn, Markus Raderer, Barbara Kiesewetter
Cancer Treatment Reviews (2024) Vol. 133, pp. 102878-102878
Open Access
Is There a Place for Temozolomide plus Nivolumab among Neuroendocrine Neoplasms?
Maria A. Velez, Edward B. Garon
Clinical Cancer Research (2022) Vol. 29, Iss. 4, pp. 691-693
Closed Access
Maria A. Velez, Edward B. Garon
Clinical Cancer Research (2022) Vol. 29, Iss. 4, pp. 691-693
Closed Access
